Abstract:We recently reported that mice with a T cell-restricted expression of a dominant negative form of transforming growth factor P receptor type II (dnTGF Rho beta RII) spontaneously develop autoimmune cholangitis that resembles human primary biliary cirrhosis (PBC), including antimitochondrial antibodies (AMAs) and extensive portal CD4(+) and CD8(+) lymphocytic infiltrates. On the basis of these data, we performed a series of experiments to determine whether the pathology was secondary to direct dnTGF beta RII disruption of the liver and/or alternatively the appearance of autoreactive T cells. First, using dnTGF beta RIIRag1(-/-) mice, we noted a normal hepatic and biliary structure. Hence, we performed a rigorous series of adoptive transfer studies, transferring Ly5.1(+) unfractionated spleen cell CD4(+) or CD8(+) T cells from dnTGF beta RII mice into B6/Rag(-/-) (Ly 5.2) recipients. In unmanipulated dnTGF beta RII mice, there was a marked increase in CD4(+) and CD8(+) T cell biliary infiltrates with AMA. indeed, B6/Rag(-/-) recipients of dnTGF beta RII unfractionated cells develop features of liver disease similar to PBC, suggesting that splenic loss of self-tolerance alone is sufficient to cause disease in this model and therefore that there is no specific abnormality in the biliary targets required for appearance of disease. More importantly, adoptive transfer of CD8(+) but not CD4(+) T cells into B6/Rag(-/-) mice led to liver histopathology remarkably similar to PBC, emphasizing a prominent role for CD8 T cell-mediated pathogenesis. In contrast, B6/ Rag(-/-) recipients of CD4(+) T cells from dnTGF beta RII mice predominantly developed inflammatory bowel disease associated with higher levels of serum interferon gamma and tumor necrosis factor alpha. Conclusion: These data suggest that in this model of PBC, autoreactive CD8(+) cells destroy bile ducts.

Liver-resident NK Cells Suppress Autoimmune Cholangitis and Limit the Proliferation of CD4+ T Cells

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.

Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis.

Natural Killer T Cells Play a Necessary Role in Modulating of Immune-Mediated Liver Injury by Gut Microbiota

Lamina Propria Interleukin 17 A Aggravates Natural Killer T-cell Activation in Autoimmune Hepatitis

Enterogenous Bacterial Glycolipids Are Required for the Generation of Natural Killer T Cells Mediated Liver Injury

Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells

IL-17A produced by invariant natural killer T cells and CD3(+)CD56(+)alpha Galcer-CD1d tetramer(-) T cells promote liver fibrosis in patients with primary biliary cholangitis

IL-17A produced by invariant natural killer T cells and CD3+CD56+αGalcer-CD1d tetramer– T cells promote liver fibrosis in patients with primary biliary cholangitis

Deletion of Interleukin-12p40 Suppresses Autoimmune Cholangitis in Dominant Negative Transforming Growth Factor Beta Receptor Type Ii Mice

Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity

Natural Killer T Cells Exacerbate Liver Injury In A Transforming Growth Factor Beta Receptor Ii Dominant-Negative Mouse Model Of Primary Biliary Cirrhosis

Natural Killer Cells in Liver Diseases

Adoptive Transfer Of Cd8(+) T Cells From Transforming Growth Factor Beta Receptor Type Ii (Dominant Negative Form) Induces Autoimmune Cholangitis In Mice

Γδt Cells Suppress Liver Fibrosis Via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells

Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver

Invariant NKT cells exacerbate liver injury in a TGF-beta receptor II dominant-negative mouse model of primary biliary cirrhosis

Liver stroma enhances activation of TLR3-triggered NK cells through fibronectin.

Targeting pathogenic CD8+ tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis

Double-Negative T Cells Promote Liver Fibrosis Progression by Regulating Treg/Th17

CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice Via Membrane-Bound TGF-β and OX40